CU20120163A7 - Intermedios de agomelatina y método de preparación de éstos - Google Patents

Intermedios de agomelatina y método de preparación de éstos

Info

Publication number
CU20120163A7
CU20120163A7 CUP2012000163A CU20120163A CU20120163A7 CU 20120163 A7 CU20120163 A7 CU 20120163A7 CU P2012000163 A CUP2012000163 A CU P2012000163A CU 20120163 A CU20120163 A CU 20120163A CU 20120163 A7 CU20120163 A7 CU 20120163A7
Authority
CU
Cuba
Prior art keywords
agomelatine
preparation
intermediate compounds
intermediates
present
Prior art date
Application number
CUP2012000163A
Other languages
English (en)
Other versions
CU24148B1 (es
Inventor
Peng Zhang
Yu Huang
Zhedong Yuan
Hanbin Shan
Xiong Yu
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45097542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU20120163(A7) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of CU20120163A7 publication Critical patent/CU20120163A7/es
Publication of CU24148B1 publication Critical patent/CU24148B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/06—Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Battery Electrode And Active Subsutance (AREA)

Abstract

La presente invención se refiere a los compuestos intermedios para la preparación de agomelatina, así como a los métodos de preparación de éstos.El intermedio de la presente invención para la preparación de agomelatina es el compuesto A y/o el compuesto B como se muestra en la fórmula siguiente. También se proporcionan dos compuestos intermedios nuevos.Cuando se usan estos compuestos intermedios nuevos para preparar agomelatina, es sencillo de manipular,bien controlado y con alta pureza, sin operaciones complicadas tales como rectificación y separación por cromatografía en columna, y adecuado para la producción industrial. Por otro lado, los métodos de preparación de los dos intermedios nuevos en sí mismos son sencillos y con alto rendimiento, usando sólo la usada muy comúnmente 7-metoxi-tetralona como material de partida original y que experimenta una etapa de reacción para obtener los intermedios, seguido de una etapa más para convertir los compuestos intermedios en el producto deseado agomelatina.Dichos procesos de reacción están muy simplificados, mejorándose el rendimiento de la reacción y superando la dificultad de purificación del método previo, comparado con la técnica anterior para la preaparación de agomelatina.Típicamente, el rendimiento de la presente invención es mayor del 70%. Espacio para Fórmula
CU20120163A 2010-06-08 2011-06-08 Intermedios de agomelatina y método de preparación de éstos CU24148B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2010101973700A CN102276492B (zh) 2010-06-08 2010-06-08 阿戈美拉汀中间体及其制备方法
PCT/CN2011/075438 WO2011153939A1 (en) 2010-06-08 2011-06-08 Agomelatine intermediates and preparation method thereof

Publications (2)

Publication Number Publication Date
CU20120163A7 true CU20120163A7 (es) 2013-01-30
CU24148B1 CU24148B1 (es) 2016-02-29

Family

ID=45097542

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20120163A CU24148B1 (es) 2010-06-08 2011-06-08 Intermedios de agomelatina y método de preparación de éstos

Country Status (41)

Country Link
US (1) US8779199B2 (es)
EP (1) EP2580189B1 (es)
JP (1) JP5519863B2 (es)
KR (1) KR101470874B1 (es)
CN (1) CN102276492B (es)
AP (1) AP3205A (es)
AU (1) AU2011264206B2 (es)
BR (1) BR112012031086B1 (es)
CA (1) CA2801822C (es)
CL (1) CL2012003371A1 (es)
CR (1) CR20120592A (es)
CU (1) CU24148B1 (es)
CY (1) CY1119857T1 (es)
DK (1) DK2580189T3 (es)
EA (1) EA020271B1 (es)
EC (1) ECSP12012328A (es)
ES (1) ES2656968T3 (es)
GE (1) GEP20156234B (es)
GT (1) GT201200328A (es)
HR (1) HRP20171751T1 (es)
HU (1) HUE035850T2 (es)
IL (1) IL223180A (es)
LT (1) LT2580189T (es)
MA (1) MA34292B1 (es)
ME (1) ME02992B (es)
MX (1) MX2012013870A (es)
MY (1) MY160954A (es)
NI (1) NI201200177A (es)
NO (1) NO2580189T3 (es)
NZ (1) NZ604081A (es)
PE (1) PE20130252A1 (es)
PH (1) PH12012502275A1 (es)
PL (1) PL2580189T3 (es)
PT (1) PT2580189T (es)
RS (1) RS56659B1 (es)
SG (1) SG185667A1 (es)
SI (1) SI2580189T1 (es)
TN (1) TN2012000542A1 (es)
UA (1) UA104684C2 (es)
WO (1) WO2011153939A1 (es)
ZA (1) ZA201208764B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012046253A2 (en) * 2010-10-08 2012-04-12 Msn Laboratories Limited Process for the preparation of n-[2- (7-methoxy-l-naphthyl) ethyl] acetamide and its novel crystalline forms
CN102452951B (zh) * 2010-10-25 2014-02-19 天津泰普药品科技发展有限公司 阿戈美拉汀及其药物组合物
ITMI20121444A1 (it) 2012-08-27 2014-02-28 Procos Spa Processo per la produzione di agomelatine
WO2014056421A1 (zh) * 2012-10-09 2014-04-17 江西同和药业有限责任公司 1-氰基-1-(7-甲氧基-1-萘基)甲醇酯类化合物及其制备方法和应用
CN112574066B (zh) * 2019-09-27 2024-10-25 江苏豪森药业集团有限公司 一种阿戈美拉汀中间体的制备方法
BR112022012342A2 (pt) * 2019-12-23 2022-09-06 Dsm Ip Assets Bv Processo de desidrogenação
CN117964510B (zh) * 2024-01-31 2026-05-19 浙江东亚药业股份有限公司 一种阿戈美拉汀的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE10229842A1 (de) 2002-07-03 2004-02-05 Helmut Prof. Dr. Schmidhammer Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung
FR2866335B1 (fr) 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
FR2866336B1 (fr) * 2004-02-13 2006-03-24 Servier Lab Nouveau procede de synthese du (7-methoxy-3,4-dihydro-1-naphtalenyl) acetonitrile et application a la synthese de l'agomelatine
FR2866334B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese du (7-methoxy-1-naphtyl) acetonitrile et application a la synthese de l'agomelatine
MX2008015843A (es) * 2006-06-20 2009-01-09 Hoffmann La Roche Derivados de tetralina e indano y usos de los mismos.
CN101486665B (zh) * 2009-03-03 2013-04-17 上海医药工业研究院 阿戈美拉汀中间体2-(7-甲氧基-1-萘基)乙酰胺的制备方法
WO2012093402A1 (en) * 2011-01-04 2012-07-12 Symed Labs Limited Processes for the preparation of n-[2-(7-methoxy-1-naphthyl)ethyl]acetamide

Also Published As

Publication number Publication date
AP2013006659A0 (en) 2013-01-31
GEP20156234B (en) 2015-01-26
SI2580189T1 (en) 2018-01-31
BR112012031086B1 (pt) 2020-12-08
HUE035850T2 (en) 2018-05-28
ME02992B (me) 2018-10-20
HRP20171751T1 (hr) 2017-12-29
IL223180A (en) 2014-06-30
KR101470874B1 (ko) 2014-12-09
LT2580189T (lt) 2017-12-11
MY160954A (en) 2017-03-31
RS56659B1 (sr) 2018-03-30
JP2013531639A (ja) 2013-08-08
KR20130028134A (ko) 2013-03-18
AU2011264206B2 (en) 2013-08-15
DK2580189T3 (da) 2018-01-29
CA2801822C (en) 2015-03-24
CA2801822A1 (en) 2011-12-15
CN102276492B (zh) 2013-04-10
ES2656968T3 (es) 2018-03-01
SG185667A1 (en) 2012-12-28
CU24148B1 (es) 2016-02-29
US8779199B2 (en) 2014-07-15
EA020271B1 (ru) 2014-09-30
PL2580189T3 (pl) 2018-04-30
NZ604081A (en) 2014-01-31
ECSP12012328A (es) 2012-12-28
WO2011153939A1 (en) 2011-12-15
GT201200328A (es) 2014-06-09
CR20120592A (es) 2013-03-04
EP2580189A1 (en) 2013-04-17
IL223180A0 (en) 2013-02-03
PT2580189T (pt) 2017-12-06
EP2580189A4 (en) 2016-01-06
NO2580189T3 (es) 2018-03-24
AP3205A (en) 2015-03-31
PE20130252A1 (es) 2013-03-16
CN102276492A (zh) 2011-12-14
ZA201208764B (en) 2014-01-29
PH12012502275A1 (en) 2022-10-05
CY1119857T1 (el) 2018-06-27
EP2580189B1 (en) 2017-10-25
UA104684C2 (ru) 2014-02-25
MX2012013870A (es) 2013-01-24
NI201200177A (es) 2013-02-06
JP5519863B2 (ja) 2014-06-11
TN2012000542A1 (en) 2014-04-01
US20130267738A1 (en) 2013-10-10
AU2011264206A1 (en) 2012-12-13
BR112012031086A2 (pt) 2017-06-20
CL2012003371A1 (es) 2013-03-22
EA201201666A1 (ru) 2013-05-30
MA34292B1 (fr) 2013-06-01

Similar Documents

Publication Publication Date Title
ECSP12012328A (es) Intermedios de agomelatina y método
EA202090917A1 (ru) Получение псилоцибина, различных полиморфных форм, промежуточных соединений, составов и их применение
WO2014043706A8 (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
BRPI0814126A2 (pt) Processo para a preparação de drospirenona
EP4417605A3 (en) Method for synthesis of eliglustat and intermediate compounds thereof
EA201000989A1 (ru) Способ получения цеолитов ts-1
WO2008096372A3 (en) Process for preparing highly pure ezetimibe using novel intermediates
IN2014DN02166A (es)
BR112022006052A2 (pt) Processo para a preparação de protioconazol
BR112017017066A2 (pt) método de preparação para praziquantel e compostos intermediários do mesmo
WO2012115402A3 (en) Crystalline form of docetaxel and process for preparation thereof
MX2018010128A (es) Toxina nueva y metodo de preparacion de un intermediario de la misma.
CO6592020A2 (es) Intemedios de agomelatina y método de preparación de éstos
MY165659A (en) Novel method of preparing benzoimidazole derivatives
MX349752B (es) Proceso para la preparacion de 3-metilsulfonilpropionitrilo.
EA200801348A1 (ru) Способ получения промежуточных соединений хлорамфеникола или его аналогов
IN2014DN08226A (es)
BR112014029361A2 (pt) método de produção de ácido tereftálico e seus derivados
PH12021550022A1 (en) Spirobiindane derivatives and a process for preparation thereof
WO2015188243A9 (en) PROCESS FOR PREPARING IMATINIB AND IMATINIB MESYLATE NON-NEEDLE SHAPED α2 FORM
IL291617A (en) Process for preparing 1-indanone compounds by intramolecular friedel-crafts reaction of alpha,alpha-dialkylmalonate derivatives
BR112014017366A2 (pt) processo de produção de acrilato de 2-octila por transesterificação
BR112022009761A2 (pt) Processo de preparação de análogos de araquidonoiletanolamina
WO2009010991A3 (en) Purification process to prepare highly pure anastrozole
WO2012134206A3 (en) Process for the preparation of anhydrous aripiprazole crystal form ii

Legal Events

Date Code Title Description
FG Grant of patent